A 28-day phase 1b MAD study in participants with overweight or obesity demonstrates safety and tolerability at daily doses of 30 mg, 60 mg, and 90 mg with mean weight loss of 1.6%, 5.2%, and 5.4%, respectively, compared to 0.5% for placebo ( 2
Agronomy 12(8):1812 Arslan NP, Dawar P, Albayrak S, Doymus M, Azad F, Esim N, Taskin M (2023) Fungi-derived natural antioxidants
In line with BOMSS (British Obesity and Metabolic Surgery Society) guidance , this typically includes a complete multivitamin and mineral supplement, iron, calcium with vitamin D, and vitamin B12 (which may need to be given by injection in some patients)
The volunteers were randomly assigned to receive semaglutide (up to 2.4 milligrams, the highest dose currently approved for obesity treatment) or placebo over a 72-week period
Its safety and effectiveness have not been established for patients under 18, so it is not recommended for use in children or adolescents.